IBDEI3BZ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,2409,0)
 ;;=MENTAL HEALTH^18^185
 ;;^UTILITY(U,$J,358.4,2410,0)
 ;;=ABDOMINAL/GASTRO/DIGESTIVE^1^185
 ;;^UTILITY(U,$J,358.4,2411,0)
 ;;=ANEMIA/BLOOD^2^185
 ;;^UTILITY(U,$J,358.4,2412,0)
 ;;=BREAST/SKIN/HAIR/NAIL/SOFT TISSUE^3^185
 ;;^UTILITY(U,$J,358.4,2413,0)
 ;;=CANCER^4^185
 ;;^UTILITY(U,$J,358.4,2414,0)
 ;;=CARDIO/VASCULAR^5^185
 ;;^UTILITY(U,$J,358.4,2415,0)
 ;;=EAR/HEARING^7^185
 ;;^UTILITY(U,$J,358.4,2416,0)
 ;;=EAR/HEARING-VESTIBULAR FUNCTION^8^185
 ;;^UTILITY(U,$J,358.4,2417,0)
 ;;=ENDOCRINE/METABOLIC/NUTRITIONAL^9^185
 ;;^UTILITY(U,$J,358.4,2418,0)
 ;;=EYE/VISION DISORDERS^10^185
 ;;^UTILITY(U,$J,358.4,2419,0)
 ;;=FALLS-INITIAL^11^185
 ;;^UTILITY(U,$J,358.4,2420,0)
 ;;=GENITOURINARY^15^185
 ;;^UTILITY(U,$J,358.4,2421,0)
 ;;=INFECTION^16^185
 ;;^UTILITY(U,$J,358.4,2422,0)
 ;;=KIDNEY/RENAL^17^185
 ;;^UTILITY(U,$J,358.4,2423,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^19^185
 ;;^UTILITY(U,$J,358.4,2424,0)
 ;;=NEUROLOGICAL/CEREBROVASCULAR^20^185
 ;;^UTILITY(U,$J,358.4,2425,0)
 ;;=PAIN^21^185
 ;;^UTILITY(U,$J,358.4,2426,0)
 ;;=PULMONARY/RESPIRATORY^22^185
 ;;^UTILITY(U,$J,358.4,2427,0)
 ;;=SLEEP DISORDERS^23^185
 ;;^UTILITY(U,$J,358.4,2428,0)
 ;;=SYMPTOMS/OTHER CONDITIONS^25^185
 ;;^UTILITY(U,$J,358.4,2429,0)
 ;;=FALLS-SEQUELA^12^185
 ;;^UTILITY(U,$J,358.4,2430,0)
 ;;=FALLS-SUBSEQUENT^13^185
 ;;^UTILITY(U,$J,358.4,2431,0)
 ;;=FUNCTION/GAIT/MOBILITY^14^185
 ;;^UTILITY(U,$J,358.4,2432,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^24^185
 ;;^UTILITY(U,$J,358.4,2433,0)
 ;;=HOSPICE CARE SUPERVISION^2^186
 ;;^UTILITY(U,$J,358.4,2434,0)
 ;;=PROLONGED SERVICES^3^186
 ;;^UTILITY(U,$J,358.4,2435,0)
 ;;=ADVANCE CARE PLANNING^1^186
 ;;^UTILITY(U,$J,358.4,2436,0)
 ;;=TEAM CONFERENCE^4^186
 ;;^UTILITY(U,$J,358.4,2437,0)
 ;;=NEOPLASMS^9^187
 ;;^UTILITY(U,$J,358.4,2438,0)
 ;;=CARDIOVASCULAR DISORDERS^2^187
 ;;^UTILITY(U,$J,358.4,2439,0)
 ;;=MENTAL HEALTH^8^187
 ;;^UTILITY(U,$J,358.4,2440,0)
 ;;=NEUROLOGICAL CONDITIONS^10^187
 ;;^UTILITY(U,$J,358.4,2441,0)
 ;;=GI DISORDERS^5^187
 ;;^UTILITY(U,$J,358.4,2442,0)
 ;;=LIVER DISORDERS^7^187
 ;;^UTILITY(U,$J,358.4,2443,0)
 ;;=KIDNEY DISORDERS^6^187
 ;;^UTILITY(U,$J,358.4,2444,0)
 ;;=RESPIRATORY DISORDERS^11^187
 ;;^UTILITY(U,$J,358.4,2445,0)
 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^187
 ;;^UTILITY(U,$J,358.4,2446,0)
 ;;=OTHER CONDITIONS^13^187
 ;;^UTILITY(U,$J,358.4,2447,0)
 ;;=DEMENTIA^3^187
 ;;^UTILITY(U,$J,358.4,2448,0)
 ;;=GENERAL IM^4^187
 ;;^UTILITY(U,$J,358.4,2449,0)
 ;;=OTHER BACTERIAL DISEASES^12^187
 ;;^UTILITY(U,$J,358.4,2450,0)
 ;;=INPATIENT CONSULTATIONS^1^188
 ;;^UTILITY(U,$J,358.4,2451,0)
 ;;=INITIAL INPATIENT CARE^2^188
 ;;^UTILITY(U,$J,358.4,2452,0)
 ;;=SUBSEQUENT INPATIENT CARE^3^188
 ;;^UTILITY(U,$J,358.4,2453,0)
 ;;=DISCHARGE/PRONOUNCEMENT^4^188
 ;;^UTILITY(U,$J,358.4,2454,0)
 ;;=NH INITIAL INPATIENT CARE^5^188
 ;;^UTILITY(U,$J,358.4,2455,0)
 ;;=NH SUBSEQUENT INPATIENT CARE^6^188
 ;;^UTILITY(U,$J,358.4,2456,0)
 ;;=NH DISCHARGE/PRONOUNCEMENT^7^188
 ;;^UTILITY(U,$J,358.4,2457,0)
 ;;=HOSPICE CARE SUPERVISION^4^189
 ;;^UTILITY(U,$J,358.4,2458,0)
 ;;=ADVANCE LIFE PLANNING^2^189
 ;;^UTILITY(U,$J,358.4,2459,0)
 ;;=EDUCATION^3^189
 ;;^UTILITY(U,$J,358.4,2460,0)
 ;;=NON-VIDEO MONITORING^5^189
 ;;^UTILITY(U,$J,358.4,2461,0)
 ;;=TEAM CONFERENCE^7^189
 ;;^UTILITY(U,$J,358.4,2462,0)
 ;;=PROLONGED SERVICES^6^189
 ;;^UTILITY(U,$J,358.4,2463,0)
 ;;=ADVANCE CARE PLANNING^1^189
 ;;^UTILITY(U,$J,358.4,2464,0)
 ;;=NEW PATIENT ^2^190
